These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31837244)

  • 21. [Pregnancy after isotretinoin use].
    Manders KC; de Vries LC; Roumen FJ
    Ned Tijdschr Geneeskd; 2013; 157(41):A6567. PubMed ID: 24103139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The need for restricted prescription of retinoic acid derivative isotretinoin to prevent retinoid teratogenicity.
    De Santis M; Straface G; Cavaliere A; Nobili E; Caruso A
    Prev Med; 2007; 45(2-3):243-4. PubMed ID: 17640721
    [No Abstract]   [Full Text] [Related]  

  • 23. Pregnancy Outcomes in Women With Moderate-to-Severe Psoriasis From the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
    Kimball AB; Guenther L; Kalia S; de Jong EMGJ; Lafferty KP; Chen DY; Langholff W; Shear NH
    JAMA Dermatol; 2021 Mar; 157(3):301-306. PubMed ID: 33533924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of pregnancy after discontinuation of isotretinoin.
    Dai WS; Hsu MA; Itri LM
    Arch Dermatol; 1989 Mar; 125(3):362-5. PubMed ID: 2923442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy.
    Henry D; Dormuth C; Winquist B; Carney G; Bugden S; Teare G; Lévesque LE; Bérard A; Paterson JM; Platt RW;
    CMAJ; 2016 Jul; 188(10):723-730. PubMed ID: 27114489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pregnancy outcomes following first-trimester exposure to topical retinoids: a systematic review and meta-analysis.
    Kaplan YC; Ozsarfati J; Etwel F; Nickel C; Nulman I; Koren G
    Br J Dermatol; 2015 Nov; 173(5):1132-41. PubMed ID: 26215715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.
    Winterfeld U; Allignol A; Panchaud A; Rothuizen LE; Merlob P; Cuppers-Maarschalkerweerd B; Vial T; Stephens S; Clementi M; De Santis M; Pistelli A; Berlin M; Eleftheriou G; Maňáková E; Buclin T
    BJOG; 2013 Mar; 120(4):463-71. PubMed ID: 23194157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. We Pledge to Change iPLEDGE.
    Pierson JC; Ferris LK; Schwarz EB
    JAMA Dermatol; 2015 Jul; 151(7):701-2. PubMed ID: 25853235
    [No Abstract]   [Full Text] [Related]  

  • 29. Teratogenicity of isotretinoin revisited: species variation and the role of all-trans-retinoic acid.
    Nau H
    J Am Acad Dermatol; 2001 Nov; 45(5):S183-7. PubMed ID: 11606951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Terminations of pregnancy associated with isotretinoin use in New Zealand.
    Moodie P; Jaine R; Arnold J; Metcalfe S; Bignall M; Arroll B
    N Z Med J; 2011 Jul; 124(1339):59-66. PubMed ID: 21952331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isotretinoin: controversies, facts, and recommendations.
    Bauer LB; Ornelas JN; Elston DM; Alikhan A
    Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1435-1442. PubMed ID: 27414637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Be smart, be safe, be sure". The revised Pregnancy Prevention Program for women on isotretinoin.
    Perlman SE; Leach EE; Dominguez L; Ruszkowski AM; Rudy SJ
    J Reprod Med; 2001 Feb; 46(2 Suppl):179-85. PubMed ID: 11255826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isotretinoin: update on controversial issues.
    Prevost N; English JC
    J Pediatr Adolesc Gynecol; 2013 Oct; 26(5):290-3. PubMed ID: 24147278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [30 years with isotretinoin. "Miracle medicine" against acne with many side effects].
    Mobacken H; Sundström A; Vahlquist A
    Lakartidningen; 2014 Jan 15-28; 111(3-4):93-6. PubMed ID: 24552013
    [No Abstract]   [Full Text] [Related]  

  • 35. Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services.
    Hoeltzenbein M; Elefant E; Vial T; Finkel-Pekarsky V; Stephens S; Clementi M; Allignol A; Weber-Schoendorfer C; Schaefer C
    Am J Med Genet A; 2012 Mar; 158A(3):588-96. PubMed ID: 22319001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Exposure to isotretinoin during pregnancy in France: 25 years of follow-up].
    Rouzès A; Jonville-Béra AP
    Therapie; 2014; 69(1):53-63. PubMed ID: 24698189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study.
    McKenna K; Koren G; Tetelbaum M; Wilton L; Shakir S; Diav-Citrin O; Levinson A; Zipursky RB; Einarson A
    J Clin Psychiatry; 2005 Apr; 66(4):444-9; quiz 546. PubMed ID: 15816786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral isotretinoin and pregnancy prevention programmes.
    Thiboutot D; Gollnick H; Bettoli V; Dréno B; Kang S; Leyden JJ; Shalita A; Torres V;
    Br J Dermatol; 2012 Feb; 166(2):466-7; author reply 467-8. PubMed ID: 21985025
    [No Abstract]   [Full Text] [Related]  

  • 39. Induced abortion. Effects of marital status, age and parity on choice of pregnancy termination.
    Skjeldestad FE; Borgan JK; Daltveit AK; Nymoen EH
    Acta Obstet Gynecol Scand; 1994 Mar; 73(3):255-60. PubMed ID: 8122509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of spontaneous abortions--the effect of previous abortions.
    Anokute CC
    J R Soc Health; 1987 Feb; 107(1):31-3. PubMed ID: 3102738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.